DEVELOPMENT OF NEW ASCIA SUBCUTANEOUS IMMUNOGLOBULIN (SCIG) RESOURCES

Methods: the first TAPID face to face meeting was held in 2014, the TAPID project membership has increased from 12 to over 90 members.Teleconferences are now held each month and face to face meetings have been held in Melbourne in 2017 (20-21 May) and 2018 (5-6 May).Case discussion forms (deidentified) are completed for each case and these are circulated to the group prior to each meeting.More than 90 cases have been discussed since 2014. Conclusion:HSCT is an important and potentially life-saving treatment option for some PIDs, particularly T cell disorders.These are complex disorders and patients benefit greatly from a team-based approach to management.The ASCIA TAPID project enables these complex PID and transplantation cases to be discussed in a confidential multi-national expert forum, to help improve patient outcomes.